RxDoctor Payments DataLook up a doctor →

Novoeight: payments to doctors

Payments that named Novoeight as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$164K
Providers
460
Transactions
812
Average per transaction
$202

The per-transaction average — $202 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 460 providers the average total is $357, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novo Nordisk Health Care AG$119,52272.7%
Novo Nordisk$44,82827.3%
← All drugs & devices